LH

Laboratory Corp
NYSE

Real-time Quotes | Nasdaq Last Sale

170.27
+3.24
+1.94%
Closed 16:28 07/02 EDT
OPEN
169.17
PREV CLOSE
167.03
HIGH
171.18
LOW
168.26
VOLUME
1.07M
TURNOVER
--
52 WEEK HIGH
196.36
52 WEEK LOW
98.02
MARKET CAP
16.55B
P/E (TTM)
52.41
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average LH stock price target is 210.43 with a high estimate of 244.00 and a low estimate of 183.00.

EPS

LH News

More
IDEXX Gains on Diagnostics Revenues, New Coronavirus Tests
Zacks · 2d ago
Boston Scientific's (BSX) ICM System Receives FDA Approval
Zacks · 2d ago
Here's Why You Should Retain DaVita in Your Portfolio Now
Investor confidence is high on DaVita (DVA), thanks to solid prospects.
Zacks · 2d ago
Myriad Genetics Unveils New Home DNA Sample Collection Kit
Zacks · 3d ago
U.S. already at 100,000 new coronavirus cases a day, it just isn't testing them all, former FDA Commissioner Gottlieb says
"States like Texas and Florida, they're falling behind on testing right now because the testing isn't evenly distributed across the country," former FDA Commissioner Dr. Scott Gottlieb said.
CNBC.com · 4d ago
4 Cheap MedTech Stocks Poised to Beat Industry Post-Pandemic
Zacks · 4d ago
NextGen Virtual Visits Offers Remote Eye Care Facilities
Zacks · 4d ago
Walgreens says new small-format store personalizes care, could help in 'pharmacy deserts'
Expect to see fewer front-of-store items, a slimmed down selection of over-the-counter medications and an emphasis on relationships between pharmacists and customers.
CNBC.com · 5d ago

Industry

Healthcare Facilities & Services
+0.90%
Healthcare Providers & Services
+0.44%

Hot Stocks

Symbol
Price
%Change

About LH

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.
More

Webull offers kinds of Laboratory Corp. of America Holdings stock information, including NYSE:LH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LH stock methods without spending real money on the virtual paper trading platform.